Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Cancer Research|October 1, 1993
A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancerM N Saleh, M B Khazaeli, W E Grizzle, et al.Cancer Research|October 15, 1991
Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humansM B Khazaeli, M N Saleh, T P Liu, et al.Human Antibodies and Hybridomas|October 1, 1993
Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancerR F Meredith, M B Khazaeli, W E Grizzle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's diseaseR T Silver, D C Case, R H Wheeler, et al.Human Antibodies and Hybridomas|January 1, 1992
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49R F Meredith, A J Bueschen, M B Khazaeli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancerJ N Ingle, V J Suman, P A Johnson, et al.Nuclear Medicine Communications|December 1, 1985
The use of a vasoconstrictor to improve tumour blood flow in intra-arterial chemotherapy: preliminary reportH A Ziessman, A A Forastiere, R H Wheeler, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiationM N Saleh, K P Raisch, M A Stackhouse, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.Pageof 8